AbbVie’s Humira was in an unfamiliar spot last month: second place. The anti-inflammatory blockbuster ranked No. 2 in overall pharma TV ad spending, behind Pfizer’s Lyrica, for the month of September, ...
AbbVie’s Humira and Pfizer’s Lyrica remained in the Nos. 1 and 2 spots for pharma TV ad spending in March, according to realtime TV ad tracker iSpot.tv, with little change for either in spending from ...
The second in a pair of complementary spots for AbbVie’s immunology drug Humira recently hit airwaves, and while it shed some light on the mysterious ad that preceded it, the sequence has elicited a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback